Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1143-1147

  Ednie, Lois M ^a   Rattan, Ashok ^b   Jacobs, Michael R ^c   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b RANBAXY RESEARCH LABORATORIES   (India)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GATIFLOXACIN; IMIPENEM; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; RANBEZOLID; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; DRUG EFFECT; DRUG STRUCTURE; EUBACTERIUM; FUSOBACTERIUM; GRAM NEGATIVE ANAEROBIC BACTERIA; LACTOBACILLUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CULTURE MEDIA; FURANS; GRAM-NEGATIVE ANAEROBIC BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; OXAZOLES;

EID: 0037416973     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1143-1147.2003     Document Type: Article

References (13)

1. Appelbaum, P. C., A. Philippon, M. R. Jacobs, S. K. Spangler, and L. Guttman. 1990. Characterization of β-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in β-lactam resistance. Antimicrob. Agents Chemother. 34:2169-2176.
2. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1990. β-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob. Agents Chemother. 34:1546-1550.
3. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1991. Susceptibilities of 394 Bacteroides fragilis, non-B, fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents. Antimicrob. Agents Chemother. 35:1214-1218.
4. Appelbaum, P. C, S. K. Spangler, and M. R. Jacobs. 1993. Susceptibility of 539 gram-positive and -negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam. J. Antimicrob. Chemother. 32:223-231.
5. Diekema, D. J., and R. N. Jones. 2000. Oxazolidinones: a review. Drugs 59:7-16.
6. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 1998. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob. Agents Chemother. 42:2459-2462.
7. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 2003. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents. J. Antimicrob. Chemother. 50:101-105.
8. Goldstein, E. J. C., D. M. Citron, and C. V. Merriam. 1999. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans. Antimicrob. Agents Chemother. 43:1469-1474.
9. Hoellmam, D. B., L. M. Kelly, M. R. Jacobs, and P. C. Appelbaum. 2001. Comparative antianaerobic activity of BMS 284756. Antimicrob. Agents Chemother. 45:589-592.
10. Livermore, D. M. 2000. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J. Antimicrob. Chemother. 46:347-350.
11. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard. NCCLS publication no. M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Summanen, P., E. J. Baron, D. M. Citron, A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
13. Wise, R., J. M. Andrews, F. J. Boswell, and J. P. Ashby. 1998. The in-vitro activity of linezolid (U-100766) and tentative breakpoints. J. Antimicrob. Chemother. 42:721-728.